Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2005 1
2006 2
2007 1
2008 11
2009 7
2016 1
2017 1
2018 2
2019 3
2020 3
2022 2
2023 2
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

34 results

Results by year

Filters applied: . Clear all
Page 1
Showing results for yuefen zhou
Search for Yefen Zhu instead (1 results)
Validation of different personalized risk models of chemotherapy-induced nausea and vomiting: results of a randomized, double-blind, phase III trial of fosaprepitant for cancer patients treated with high-dose cisplatin.
Zhao Y, Zhao B, Chen G, Chen Y, Liao Z, Zhang H, Feng W, Li Y, Weng H, Li W, Zhou Y, Ren B, Lu Y, Chen J, Liu Z, Su Z, Wang W, Zhang L. Zhao Y, et al. Among authors: zhou y. Cancer Commun (Lond). 2023 Feb;43(2):246-256. doi: 10.1002/cac2.12397. Epub 2022 Dec 22. Cancer Commun (Lond). 2023. PMID: 36545810 Free PMC article. Clinical Trial.
Penpulimab, an anti-PD1 IgG1 antibody in the treatment of advanced or metastatic upper gastrointestinal cancers.
Zheng Y, Mislang ARA, Coward J, Cosman R, Cooper A, Underhill C, Zhu J, Xiong J, Jiang O, Wang H, Xie Y, Zhou Y, Jin X, Li B, Wang ZM, Kwek KY, Xia D, Xia Y, Xu N. Zheng Y, et al. Among authors: zhou y. Cancer Immunol Immunother. 2022 Oct;71(10):2371-2379. doi: 10.1007/s00262-022-03160-1. Epub 2022 Feb 15. Cancer Immunol Immunother. 2022. PMID: 35165764 Free PMC article. Clinical Trial.
Chloro-oxime derivatives as novel small molecule chaperone amplifiers.
Zhou Y, Vu K, Chen Y, Pham J, Brady T, Liu G, Chen J, Nam J, Murali Mohan Reddy PS, Au Q, Yoon IS, Tremblay MH, Yip G, Cher C, Zhang B, Barber JR, Ng SC. Zhou Y, et al. Bioorg Med Chem Lett. 2009 Jun 1;19(11):3128-35. doi: 10.1016/j.bmcl.2009.03.011. Epub 2009 Mar 9. Bioorg Med Chem Lett. 2009. PMID: 19398333
Pyrrolo[1,2-b]pyridazin-2-ones as potent inhibitors of HCV NS5B polymerase.
Ruebsam F, Webber SE, Tran MT, Tran CV, Murphy DE, Zhao J, Dragovich PS, Kim SH, Li LS, Zhou Y, Han Q, Kissinger CR, Showalter RE, Lardy M, Shah AM, Tsan M, Patel R, Lebrun LA, Kamran R, Sergeeva MV, Bartkowski DM, Nolan TG, Norris DA, Kirkovsky L. Ruebsam F, et al. Among authors: zhou y. Bioorg Med Chem Lett. 2008 Jun 15;18(12):3616-21. doi: 10.1016/j.bmcl.2008.04.066. Epub 2008 May 1. Bioorg Med Chem Lett. 2008. PMID: 18487044
34 results